Zhanya Huang

机构：Peking University, Peking University Cancer Hospital, Peking University Third Hospital

发表论文 6 篇 · 总被引 83 次 · h-index 2

代表论文

• EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer (2024 · Advanced Science · 被引 48)
• Synergistic innovation in organ-on-a-chip and organoid technologies: reshaping the future of disease modeling, drug development, and precision medicine (2025 · Protein & Cell · 被引 33)
• Hypoxia promotes pancreatic adenocarcinoma progression by stabilizing ID1 via TRIM21 suppression (2025 · Frontiers in Oncology · 被引 2)
• Metabolic molecular subtyping of ovarian cancer reveals the role of oleic acid-CD36 in facilitating cisplatin resistance (2025 · Research Square)
• Bridging the gap between bench and bedside: Organoid technology in colorectal cancer treatment (2025 · Cell organoid (Print))
• EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer (Adv. Sci. 23/2024) (2024 · Advanced Science)